-
1
-
-
0033559933
-
Estimates of the worldwide incidence of 25 major cancers in 1990
-
Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999 80 : 827 41.
-
(1999)
Int J Cancer
, vol.80
, pp. 827-41
-
-
Parkin, D.M.1
Pisani, P.2
Ferlay, J.3
-
2
-
-
37349012464
-
Annual Report of Gynecologic Cancer Registry Program in Korea for 2004 (Jan. 1st, 2004-Dec. 31st, 2004)
-
SOG Gynecologic Oncology Committee.
-
SOG Gynecologic Oncology Committee. Annual Report of Gynecologic Cancer Registry Program in Korea for 2004 (Jan. 1st, 2004-Dec. 31st, 2004). Korean J Obstet Gynecol 2007 50 : 28 78.
-
(2007)
Korean J Obstet Gynecol
, vol.50
, pp. 28-78
-
-
-
4
-
-
0028036762
-
Family history and the risk of endometrial cancer
-
Parazzini F, La Vecchia C, Moroni S, Chatenoud L, Ricci E. Family history and the risk of endometrial cancer. Int J Cancer 1994 59 : 460 2.
-
(1994)
Int J Cancer
, vol.59
, pp. 460-2
-
-
Parazzini, F.1
La Vecchia, C.2
Moroni, S.3
Chatenoud, L.4
Ricci, E.5
-
5
-
-
0026621456
-
Endometrial adenocarcinoma: Genetic analysis suggesting heritable site-specific uterine cancer
-
Sandles LG, Shulman LP, Elias S, Photopulos GJ, Smiley LM, Posten WM, et al. Endometrial adenocarcinoma: genetic analysis suggesting heritable site-specific uterine cancer. Gynecol Oncol 1992 47 : 167 71.
-
(1992)
Gynecol Oncol
, vol.47
, pp. 167-71
-
-
Sandles, L.G.1
Shulman, L.P.2
Elias, S.3
Photopulos, G.J.4
Smiley, L.M.5
Posten, W.M.6
-
6
-
-
0021797997
-
Second primary malignancy in endometrial carcinoma patients
-
Schwartz Z, Ohel G, Birkenfeld A, Anteby SO, Schenker JG. Second primary malignancy in endometrial carcinoma patients. Gynecol Oncol 1985 22 : 40 5.
-
(1985)
Gynecol Oncol
, vol.22
, pp. 40-5
-
-
Schwartz, Z.1
Ohel, G.2
Birkenfeld, A.3
Anteby, S.O.4
Schenker, J.G.5
-
7
-
-
0025915010
-
Hereditary nonpolyposis colorectal cancer (Lynch syndromes i & II). Genetics, pathology, natural history, and cancer control, Part i
-
Lynch HT, Lanspa S, Smyrk T, Boman B, Watson P, Lynch J. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, Part I. Cancer Genet Cytogenet 1991 53 : 143 60.
-
(1991)
Cancer Genet Cytogenet
, vol.53
, pp. 143-60
-
-
Lynch, H.T.1
Lanspa, S.2
Smyrk, T.3
Boman, B.4
Watson, P.5
Lynch, J.6
-
8
-
-
0010066582
-
A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma
-
Semba K, Kamata N, Toyoshima K, Yamamoto T. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci USA 1985 82 : 6497 501.
-
(1985)
Proc Natl Acad Sci USA
, vol.82
, pp. 6497-501
-
-
Semba, K.1
Kamata, N.2
Toyoshima, K.3
Yamamoto, T.4
-
9
-
-
0022588467
-
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
-
Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, et al. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 1986 319 : 230 4.
-
(1986)
Nature
, vol.319
, pp. 230-4
-
-
Yamamoto, T.1
Ikawa, S.2
Akiyama, T.3
Semba, K.4
Nomura, N.5
Miyajima, N.6
-
10
-
-
0023196582
-
ErbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells
-
Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, Aaronson SA. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 1987 237 : 178 82.
-
(1987)
Science
, vol.237
, pp. 178-82
-
-
Di Fiore, P.P.1
Pierce, J.H.2
Kraus, M.H.3
Segatto, O.4
King, C.R.5
Aaronson, S.A.6
-
11
-
-
0024337144
-
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
-
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989 244 : 707 12.
-
(1989)
Science
, vol.244
, pp. 707-12
-
-
Slamon, D.J.1
Godolphin, W.2
Jones, L.A.3
Holt, J.A.4
Wong, S.G.5
Keith, D.E.6
-
12
-
-
0027787632
-
Neu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer
-
Jardines L, Weiss M, Fowble B, Greene M. neu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer. Pathobiology 1993 61 : 268 82.
-
(1993)
Pathobiology
, vol.61
, pp. 268-82
-
-
Jardines, L.1
Weiss, M.2
Fowble, B.3
Greene, M.4
-
13
-
-
0028670125
-
The biology of erbB-2/neu/HER-2 and its role in cancer
-
Hynes NE, Stern DF. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1994 1198 : 165 84.
-
(1994)
Biochim Biophys Acta
, vol.1198
, pp. 165-84
-
-
Hynes, N.E.1
Stern, D.F.2
-
14
-
-
0032993938
-
HER-2/neu amplification and overexpression in endometrial carcinoma
-
Rolitsky CD, Theil KS, McGaughy VR, Copeland LJ, Niemann TH. HER-2/neu amplification and overexpression in endometrial carcinoma. Int J Gynecol Pathol 1999 18 : 138 43.
-
(1999)
Int J Gynecol Pathol
, vol.18
, pp. 138-43
-
-
Rolitsky, C.D.1
Theil, K.S.2
McGaughy, V.R.3
Copeland, L.J.4
Niemann, T.H.5
-
15
-
-
0034473028
-
HER-2/neu (erbB-2) and the cell cycle
-
discussion 92-100.
-
Busse D, Doughty RS, Arteaga CL. HER-2/neu (erbB-2) and the cell cycle. Semin Oncol 2000 27 : 3 8 discussion 92-100.
-
(2000)
Semin Oncol
, vol.27
, pp. 3-8
-
-
Busse, D.1
Doughty, R.S.2
Arteaga, C.L.3
-
16
-
-
0036720103
-
ErbB receptor tyrosine kinase inhibitors as therapeutic agents
-
Anderson NG, Ahmad T. ErbB receptor tyrosine kinase inhibitors as therapeutic agents. Front Biosci 2002 7 : d1926 40.
-
(2002)
Front Biosci
, vol.7
, pp. 1926-40
-
-
Anderson, N.G.1
Ahmad, T.2
-
17
-
-
18744378545
-
A putative molecular-activation switch in the transmembrane domain of erbB2
-
Fleishman SJ, Schlessinger J, Ben-Tal N. A putative molecular-activation switch in the transmembrane domain of erbB2. Proc Natl Acad Sci USA 2002 99 : 15937 40.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 15937-40
-
-
Fleishman, S.J.1
Schlessinger, J.2
Ben-Tal, N.3
-
18
-
-
0034163421
-
Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk
-
Xie D, Shu XO, Deng Z, Wen WQ, Creek KE, Dai Q, et al. Population:-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst 2000 92 : 412 7.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 412-7
-
-
Xie, D.1
Shu, X.O.2
Deng, Z.3
Wen, W.Q.4
Creek, K.E.5
Dai, Q.6
-
19
-
-
10744225469
-
The HER2 I655V polymorphism and risk of breast cancer in women
-
Montgomery KG, Gertig DM, Baxter SW, Milne RL, Dite GS, McCredie MR, et al. The HER2 I655V polymorphism and risk of breast cancer in women
-
(2003)
Cancer Epidemiol Biomarkers Prev
, vol.12
, pp. 1109-11
-
-
Montgomery, K.G.1
Gertig, D.M.2
Baxter, S.W.3
Milne, R.L.4
Dite, G.S.5
McCredie, M.R.6
-
20
-
-
22544476446
-
Common ERBB2 polymorphisms and risk of breast cancer in a white British population: A case-control study
-
Benusiglio PR, Lesueur F, Luccarini C, Conroy DM, Shah M, Easton DF, et al. Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study. Breast Cancer Res 2005 7 : R204 9.
-
(2005)
Breast Cancer Res
, vol.7
, pp. 204-9
-
-
Benusiglio, P.R.1
Lesueur, F.2
Luccarini, C.3
Conroy, D.M.4
Shah, M.5
Easton, D.F.6
-
21
-
-
0035577803
-
Germ-line HER-2 variant and breast cancer risk by stage of disease
-
McKean-Cowdin R, Kolonel LN, Press MF, Pike MC, Henderson BE. Germ-line HER-2 variant and breast cancer risk by stage of disease. Cancer Res 2001 61 : 8393 4.
-
(2001)
Cancer Res
, vol.61
, pp. 8393-4
-
-
McKean-Cowdin, R.1
Kolonel, L.N.2
Press, M.F.3
Pike, M.C.4
Henderson, B.E.5
-
22
-
-
34648813962
-
Epidermal growth factor receptor and human epidermal growth factor receptor 2 gene polymorphisms in endometrial cancer in a Japanese population
-
Kitao K, Yoshida S, Kennedy S, Takemura N, Sugimoto M, Deguchi M, et al. Epidermal growth factor receptor and human epidermal growth factor receptor 2 gene polymorphisms in endometrial cancer in a Japanese population. Reprod Sci 2007 14 : 349 57.
-
(2007)
Reprod Sci
, vol.14
, pp. 349-57
-
-
Kitao, K.1
Yoshida, S.2
Kennedy, S.3
Takemura, N.4
Sugimoto, M.5
Deguchi, M.6
-
23
-
-
33846633693
-
Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk
-
Einarsdottir K, Humphreys K, Bonnard C, Li Y, Li Y, Chia KS, et al. Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk. Hum Mol Genet 2007 16 : 154 64.
-
(2007)
Hum Mol Genet
, vol.16
, pp. 154-64
-
-
Einarsdottir, K.1
Humphreys, K.2
Bonnard, C.3
Li, Y.4
Li, Y.5
Chia, K.S.6
-
24
-
-
0003922844
-
-
World Health Organization, International Association for the Study of Obesity, International Obesity Task Force. Caulfield, VIC, Australia. International Diabetes Institute
-
World Health Organization, International Association for the Study of Obesity, International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Caulfield, VIC, Australia : International Diabetes Institute, 2000.
-
(2000)
The Asia-Pacific Perspective: Redefining Obesity and Its Treatment.
-
-
-
25
-
-
0024284028
-
A simple salting out procedure for extracting DNA from human nucleated cells
-
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988 16 : 1215.
-
(1988)
Nucleic Acids Res
, vol.16
, pp. 1215
-
-
Miller, S.A.1
Dykes, D.D.2
Polesky, H.F.3
-
26
-
-
24644456556
-
New approaches for genotyping paraffin wax embedded breast tissue from patients with cancer: The Iowa women's health study
-
Thyagarajan B, Anderson KE, Kong F, Selk FR, Lynch CF, Gross MD. New approaches for genotyping paraffin wax embedded breast tissue from patients with cancer: the Iowa women's health study. J Clin Pathol 2005 58 : 955 61.
-
(2005)
J Clin Pathol
, vol.58
, pp. 955-61
-
-
Thyagarajan, B.1
Anderson, K.E.2
Kong, F.3
Selk, F.R.4
Lynch, C.F.5
Gross, M.D.6
-
27
-
-
0036598550
-
SNPstream UHT: Ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery
-
76 77 74
-
Bell PA, Chaturvedi S, Gelfand CA, Huang CY, Kochersperger M, Kopla R, et al. SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery. BioTechniques 2002 Suppl : 70 72, 74, 76 77.
-
(2002)
BioTechniques
, Issue.SUPPL.
, pp. 70-72
-
-
Bell, P.A.1
Chaturvedi, S.2
Gelfand, C.A.3
Huang, C.Y.4
Kochersperger, M.5
Kopla, R.6
-
28
-
-
18544375772
-
High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes
-
Denomme GA, Van Oene M. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005 45 : 660 6.
-
(2005)
Transfusion
, vol.45
, pp. 660-6
-
-
Denomme, G.A.1
Van Oene, M.2
-
29
-
-
0037431517
-
Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort
-
Furberg AS, Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 2003 104 : 669 76.
-
(2003)
Int J Cancer
, vol.104
, pp. 669-76
-
-
Furberg, A.S.1
Thune, I.2
-
30
-
-
0030710144
-
Diet, body size, physical activity, and the risk of endometrial cancer
-
Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, et al. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 1997 57 : 5077 85.
-
(1997)
Cancer Res
, vol.57
, pp. 5077-85
-
-
Goodman, M.T.1
Hankin, J.H.2
Wilkens, L.R.3
Lyu, L.C.4
McDuffie, K.5
Liu, L.Q.6
|